ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile

 

American Society of Hematology 

1900 M Street, NW, Suite 200

Washington  D.C.  20036  U.S.A.
Phone: 202-776-0544 Fax: 202-776-0545


SEARCH JOBS


Industry
Services






 Company News
Regen BioPharma Presented Novel Therapeutic Target For Leukemia And Myelodysplastic Syndrome At The American Society of Hematology Annual Meeting 12/12/2014 11:27:06 AM
Kamada Ltd. (KMDA) Announces Positive Interim Results From Phase 1/2 Clinical Study Of Its Human Alpha-1 Antitrypsin To Treat Graft-Versus-Host Disease Presented At American Society of Hematology Annual Meeting 12/11/2014 7:21:59 AM
Kadmon Corporation Presents Preclinical Data On KD025 In Chronic Graft-Versus-Host-Disease At American Society of Hematology Annual Meeting 12/10/2014 11:34:50 AM
Marina Biotech, Inc. (MRNA) Reports That Licensee ProNAi Therapeutics, Inc. Presented Interim Phase 2 Data On Its BCL2-Targeting DNAi® Therapeutic At American Society of Hematology 2014 12/10/2014 11:25:37 AM
Acceleron Pharma Release: Luspatercept Data On Myelodysplastic Syndromes Selected For “Best Of ASH” By The American Society of Hematology 12/10/2014 10:18:34 AM
New Data At American Society of Hematology 2014 Highlight Progress Of Pfizer (PFE)’s Growing Portfolio In Blood Cancers 12/10/2014 9:42:36 AM
Celator Pharmaceuticals, Inc. Presents Data On CPX-351 At The 56th American Society of Hematology Annual Meeting 12/10/2014 7:51:21 AM
Celgene (CELG) Release: REVLIMID® (Lenalidomide) Single-Agent And Combination Studies In Mantle Cell Lymphoma (MCL) Presented At American Society of Hematology 12/9/2014 1:04:48 PM
Alexion Pharmaceuticals Inc. (ALXN) Release: New Data Presented At American Society of Hematology Annual Meeting Enhance Clinical Knowledge Of aHUS And PNH And Underscore The Effectiveness Of Soliris® (Eculizumab) Treatment 12/9/2014 12:06:35 PM
Sevion Therapeutics Presents Results Of SNS01-T Phase 1b/2a Dose Escalation Study At American Society of Hematology Annual Meeting 12/9/2014 11:50:25 AM
12345678910...